Subscribe to RSS
DOI: 10.1055/s-0032-1315960
Patient Safety and Quality in Laboratory and Hemostasis Testing: A Renewed Loop?
Publication History
Publication Date:
02 June 2012 (online)
Abstract
More than three decades ago, George Lundberg first introduced the concept of the brain-to-brain loop for laboratory diagnostics. According to this pioneering model, the first step in the loop involves the selection of laboratory tests in the brain of the physician caring for the patient, and the final step is the transmission of test results back to the ordering physician. There are several intermediary steps, some of which are preanalytical (e.g., identification of patient and blood samples, the process of blood collection, and specimen handling); some are analytical and relate to the actual performance of the test(s); whereas others are postanalytical and involve release of test results into the medical record and further steps such as the physician's reaction to laboratory information, their interpretation of these results, and subsequent appropriate clinical action. Hemostasis testing should also be viewed within such a paradigm, so that quality throughout the total testing process can be assured. For hemostasis testing, particular attention is required to ensure provision of appropriate test samples in the preanalytical phase. Nevertheless, the timeliness of testing and an appropriate interpretation of test results are also paramount. This article overviews the concept of quality testing within hemostasis as critical to ensuring patient safety and optimal clinical and therapeutic management.
-
References
- 1 Lundberg GD. Acting on significant laboratory results. JAMA 1981; 245 (17) 1762-1763
- 2 Plebani M, Lippi G. Closing the brain-to-brain loop in laboratory testing. Clin Chem Lab Med 2011; 49 (7) 1131-1133
- 3 Lundberg GD. The need for an outcomes research agenda for clinical laboratory testing. JAMA 1998; 280 (6) 565-566
- 4 Vincent C. Patient Safety. Edinburgh: Elsevier Churchill Livingstone; 2006
- 5 Bruns DE. Laboratory-related outcomes in healthcare. Clin Chem 2001; 47 (8) 1547-1552
- 6 Porter ME. What is value in health care?. N Engl J Med 2010; 363 (26) 2477-2481
- 7 Zaninotto M, Plebani M. The “hospital central laboratory”: automation, integration and clinical usefulness. Clin Chem Lab Med 2010; 48 (7) 911-917
- 8 Lippi G, Plebani M, Simundic AM. Quality in laboratory diagnostics: from theory to practice. Biochem Med 2010; 20 (2) 126-130
- 9 Plebani M, Lippi G. Is laboratory medicine a dying profession? Blessed are those who have not seen and yet have believed. Clin Biochem 2010; 43 (12) 939-941
- 10 Favaloro EJ, Lippi G. Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?. Clin Chem Lab Med 2010; 48 (3) 309-321
- 11 Preston FE, Lippi G, Favaloro EJ, Jayandharan GR, Edison ES, Srivastava A. Quality issues in laboratory haemostasis. Haemophilia 2010; 16 (Suppl. 05) 93-99
- 12 Lippi G, Favaloro EJ. Laboratory diagnostics and appropriate care of people with haemophilia. Haemophilia 2011; 17 (5) 824-825
- 13 Bonar R, Favaloro EJ, Adcock DM. Quality in coagulation and haemostasis testing. Biochem Med 2010; 20 (2) 184-199
- 14 Lippi G, Plebani M, Favaloro EJ, Trenti T. Laboratory testing in pharmacies. Clin Chem Lab Med 2010; 48 (7) 943-953
- 15 Lippi G, Favaloro EJ, Plebani M. Direct-to-consumer testing: more risks than opportunities. Int J Clin Pract 2011; 65 (12) 1221-1229
- 16 Guidi GC, Lippi G. Laboratory medicine in the 2000s: programmed death or rebirth?. Clin Chem Lab Med 2006; 44 (8) 913-917
- 17 Plebani M, Laposata M, Lundberg GD. The brain-to-brain loop concept for laboratory testing 40 years after its introduction. Am J Clin Pathol 2011; 136 (6) 829-833
- 18 Otto CN. Patient safety and the medical laboratory using the IOM aims. Clin Lab Sci 2011; 24 (2) 108-113
- 19 Valenstein PN, Walsh MK, Meier F ; College of American Pathologists. Heparin monitoring and patient safety: a College of American Pathologists Q-Probes study of 3431 patients at 140 institutions. Arch Pathol Lab Med 2004; 128 (4) 397-402
- 20 Drewes HW, Lambooij MS, Baan CA, Meijboom BR, Graafmans WC, Westert GP. Needs and barriers to improve the collaboration in oral anticoagulant therapy: a qualitative study. BMC Cardiovasc Disord 2011; 11 (1) 76
- 21 Berrettini M, Agnelli G. Management of oral anticoagulant therapy in Italy. Semin Thromb Hemost 1999; 25 (1) 27-31
- 22 ISO 1589:2007. Medical laboratories—particular requirements for quality and competence
- 23 Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006; 44 (4) 358-365
- 24 Salvagno GL, Lippi G, Bassi A, Poli G, Guidi GC. Prevalence and type of pre-analytical problems for inpatients samples in coagulation laboratory. J Eval Clin Pract 2008; 14 (2) 351-353
- 25 Plebani M. The detection and prevention of errors in laboratory medicine. Ann Clin Biochem 2010; 47 (Pt 2) 101-110
- 26 Tufano A, Guida A, Di Minno MN, Prisco D, Cerbone AM, Di Minno G. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. Semin Thromb Hemost 2011; 37 (3) 267-274
- 27 Heleen van Ommen C, Middeldorp S. Thrombophilia in childhood: to test or not to test. Semin Thromb Hemost 2011; 37 (7) 794-801
- 28 Lippi G, Favaloro EJ, Cervellin G. Prevention of venous thromboembolism: focus on mechanical prophylaxis. Semin Thromb Hemost 2011; 37 (3) 237-251
- 29 Bikdeli B, Sharif-Kashani B. Prophylaxis for venous thromboembolism: a great global divide between expert guidelines and clinical practice?. Semin Thromb Hemost 2012; 38 (2) 144-155
- 30 Laposata ME, Laposata M, Van Cott EM, Buchner DS, Kashalo MS, Dighe AS. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med 2004; 128 (12) 1424-1427
- 31 Favaloro EJ, Lippi G. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?. Clin Chem Lab Med 2011; 49 (5) 755-757
- 32 Favaloro EJ, Lippi G, Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology 2011; 43 (7) 682-692
- 33 Barth JH. Clinical quality indicators in laboratory medicine: a survey of current practice in the UK. Ann Clin Biochem 2011; 48 (Pt 3) 238-240
- 34 Dighe AS, Soderberg BL, Laposata M. Narrative interpretations for clinical laboratory evaluations: an overview. Am J Clin Pathol 2001; 116 (Suppl) S123-S128
- 35 Laposata M, Dighe A. “Pre-pre” and “post-post” analytical error: high-incidence patient safety hazards involving the clinical laboratory. Clin Chem Lab Med 2007; 45 (6) 712-719
- 36 Lippi G, Favaloro EJ, Franchini M, Guidi GC. Milestones and perspectives in coagulation and hemostasis. Semin Thromb Hemost 2009; 35 (1) 9-22
- 37 Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008; 34 (8) 747-761
- 38 Lippi G, Franchini M, Targher G. Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 2011; 8 (9) 502-512
- 39 Favaloro EJ, McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly. Semin Thromb Hemost 2009; 35 (7) 695-710
- 40 Favaloro EJ, Reben R, Mohammed S, Koutts J. Clinical audit of antiphospholipid antibody testing in tertiary practice: towards improved relevance in thrombophilia investigations. Intern Med J 2012; 42 (4) 427-434
- 41 Favaloro EJ, Mohammed S, Pati N, Ho MY, McDonald D. A clinical audit of congenital thrombophilia investigation in tertiary practice. Pathology 2011; 43 (3) 266-272
- 42 Favaloro EJ. Assessment for antithrombin deficiency in the real world. Int J Lab Hematol 2011; 33 (6) 656-658 , author reply 659–660
- 43 Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G. The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis 2010; 29 (4) 489-496
- 44 Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC. Quality and reliability of routine coagulation testing: can we trust that sample?. Blood Coagul Fibrinolysis 2006; 17 (7) 513-519
- 45 Kiechle FL, Adcock DM, Calam RR, Davis C, Schwartz JG. So You're Going to Collect a Blood Specimen. An Introduction to Phlebotomy. 12th ed. Northfield, IL: College of American Pathologists; 2007
- 46 Lippi G, Salvagno GL, Montagnana M, Guidi GC. Short-term venous stasis influences routine coagulation testing. Blood Coagul Fibrinolysis 2005; 16 (6) 453-458
- 47 Adcock DM, Hoefner DM, Kottke-Marchant K, Marlar RA, Szamosi DI, Warunek DJ. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays: Approved Guideline. 5th ed. CLSI document H21–A5. Wayne, PA: Clinical Laboratory Standards Institute; 2008
- 48 Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?. Semin Thromb Hemost 2008; 34 (7) 612-634
- 49 Favaloro EJ, Adcock D, Lippi G. Preanalytical variables in coagulation testing associated to diagnostic errors in hemostasis. Lab Med 2012; 43 (2) 1-10
- 50 Zürcher M, Sulzer I, Barizzi G, Lämmle B, Alberio L. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost 2008; 99 (2) 416-426
- 51 Adcock DM, Kressin DC, Marlar RA. Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration. Am J Clin Pathol 1998; 109 (5) 595-599
- 52 Favaloro EJ. More on preanalytical variables affecting platelet function testing using light transmittance aggregometry. Clin Chem Lab Med 2011; 49 (4) 737-739
- 53 Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Guidi GC, Favaloro EJ. Quality standards for sample collection in coagulation testing. Sem Thromb Hemost 2012; 38 (6) 565-575
- 54 Adcock-Funk D, Lippi G, Favaloro EJ. Quality standards for sample processing, transportation and storage processing. Sem Thromb Hemost 2012; 38 (6)
- 55 Goswami B, Tayal D, Chawla R, Mallika V. Pre-analytical factors that influence the interpretation of prothrombin time in the clinical laboratory: one year experience in a super speciality hospital in India. Clin Chim Acta 2009; 410 (1-2) 93-94
- 56 Salvagno GL, Lippi G, Montagnana M, Franchini M, Poli G, Guidi GC. Influence of temperature and time before centrifugation of specimens for routine coagulation testing. Int J Lab Hematol 2009; 31 (4) 462-467
- 57 Lippi G, Salvagno GL, Montagnana M, Manzato F, Guidi GC. Influence of the centrifuge time of primary plasma tubes on routine coagulation testing. Blood Coagul Fibrinolysis 2007; 18 (5) 525-528
- 58 Fraser CG, Kallner A, Kenny D, Petersen PH. Introduction: strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999; 59 (7) 477-478
- 59 Meijer P, Haverkate F, Kluft C. Performance goals for the laboratory testing of antithrombin, protein C and protein S. Thromb Haemost 2006; 96 (5) 584-589
- 60 Plebani M, Sanzari MC, Zardo L. Quality control in coagulation testing. Semin Thromb Hemost 2008; 34 (7) 642-646
- 61 Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med 2010; 48 (5) 579-598
- 62 Favaloro EJ. Internal quality control and external quality assurance of platelet function tests. Semin Thromb Hemost 2009; 35 (2) 139-149
- 63 Favaloro EJ, Bonar R. Proficiency testing/external quality control for the PFA-100. Clin Chem Lab Med 2012; 50: 1393-1401
- 64 Perry DJ, Fitzmaurice DA, Kitchen S, Mackie IJ, Mallett S. Point-of-care testing in haemostasis. Br J Haematol 2010; 150 (5) 501-514
- 65 Favaloro EJ, Lippi G. Coagulation update: what's new in hemostasis testing?. Thromb Res 2011; 127 (Suppl) (2) S13-S16
- 66 Wegner J, Popovsky MA. Clinical utility of thromboelastography: one size does not fit all. Semin Thromb Hemost 2010; 36 (7) 699-706
- 67 Clinical Laboratory Standards Institute (CLSI). Platelet Function Testing by Aggregometry; Approved Guideline. CLSI document H58-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2008
- 68 Lippi G, Favaloro EJ. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology 2010; 74 (18) 1477 , author reply 1477–1478
- 69 Stavelin A, Meijer P, Kitchen D, Sandberg S. External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. Clin Chem Lab Med 2012; 50 (1) 81-88
- 70 Piva E, Lippi G, Plebani M. Notification of abnormal and critical values: the road ahead. Am J Med 2010; 123 (10) e19 , author reply e21
- 71 Guidi GC, Poli G, Bassi A, Giobelli L, Benetollo PP, Lippi G. Development and implementation of an automatic system for verification, validation and delivery of laboratory test results. Clin Chem Lab Med 2009; 47 (11) 1355-1360
- 72 Piva E, Sciacovelli L, Laposata M, Plebani M. Assessment of critical values policies in Italian institutions: comparison with the US situation. Clin Chem Lab Med 2010; 48 (4) 461-468
- 73 Pai M, Moffat KA, Plumhoff E, Hayward CPM. Critical values in the coagulation laboratory: results of a survey of the North American Specialized Coagulation Laboratory Association. Am J Clin Pathol 2011; 136 (6) 836-841
- 74 Piva E, Sciacovelli L, Zaninotto M, Laposata M, Plebani M. Evaluation of effectiveness of a computerized notification system for reporting critical values. Am J Clin Pathol 2009; 131 (3) 432-441
- 75 Plebani M. Exploring the iceberg of errors in laboratory medicine. Clin Chim Acta 2009; 404 (1) 16-23
- 76 Graber ML. The physician and the laboratory. Am J Clin Pathol 2005; 124 (Suppl) (1) S1-S4
- 77 Chen ET, Eder M, Elder NC, Hickner J. Crossing the finish line: follow-up of abnormal test results in a multisite community health center. J Natl Med Assoc 2010; 102 (8) 720-725
- 78 Favaloro EJ, Plebani M, Lippi G. Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing?. Clin Chem Lab Med. 2011; 49 (12) 1965-1973